000 01385 a2200373 4500
005 20250516234327.0
264 0 _c20141121
008 201411s 0 0 ger d
022 _a1439-4413
024 7 _a10.1055/s-0034-1370285
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aStarck, M
245 0 0 _a[Thrombotic microangiopathies].
_h[electronic resource]
260 _bDeutsche medizinische Wochenschrift (1946)
_cOct 2014
300 _a1993-6 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAdrenal Cortex Hormones
_xtherapeutic use
650 0 4 _aAntibodies, Monoclonal, Humanized
_xtherapeutic use
650 0 4 _aAntibodies, Monoclonal, Murine-Derived
_xtherapeutic use
650 0 4 _aCoombs Test
650 0 4 _aHemolytic-Uremic Syndrome
_xclassification
650 0 4 _aHumans
650 0 4 _aImmunosuppressive Agents
_xtherapeutic use
650 0 4 _aPlasma Exchange
650 0 4 _aPredictive Value of Tests
650 0 4 _aPrognosis
650 0 4 _aPurpura, Thrombotic Thrombocytopenic
_xclassification
650 0 4 _aRituximab
650 0 4 _aSurvival Rate
650 0 4 _aThrombotic Microangiopathies
_xclassification
700 1 _aWendtner, C-M
773 0 _tDeutsche medizinische Wochenschrift (1946)
_gvol. 139
_gno. 40
_gp. 1993-6
856 4 0 _uhttps://doi.org/10.1055/s-0034-1370285
_zAvailable from publisher's website
999 _c24221171
_d24221171